BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 501085)

  • 1. Relationship between Fc (IgG) receptors and alloantigens on the surface of BALB/c B cell lymphoma lines.
    Kanellopoulos-Langevin C; Kim KJ; Sachs DH; Asofsky R
    J Immunol; 1979 Dec; 123(6):2651-7. PubMed ID: 501085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of EA-rosette formation blockade by antisera against cell surface antigens].
    Bogdanova IM; Malaĭtsev VV
    Biull Eksp Biol Med; 1980 Oct; 90(10):453-6. PubMed ID: 7426708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunogenic and tumorigenic properties of a murine lymphoma that expresses foreign alloantigens: role of helper factor(s) in generating a cytotoxic response in vitro.
    Scott JW; Finke JH
    Transplant Proc; 1981 Dec; 13(4):1867-73. PubMed ID: 6800082
    [No Abstract]   [Full Text] [Related]  

  • 4. Serological analysis of macrophage surface alloantigens.
    Mottram PL; Potter TA; McKenzie IF; Miller JF
    Cell Immunol; 1981 Mar; 59(1):151-60. PubMed ID: 6938312
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative studies on the expression of Fc-receptors, Ia antigens, and beta 2-microglobulin following in vitro herpes simplex virus infection of human lymphoid cells.
    Dorval G; Bourkas AE; Menezes J
    Clin Exp Immunol; 1979 Sep; 37(3):477-85. PubMed ID: 92381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the lymphocytic receptor binding immunoglobulin G Fc fragment].
    Nowak J
    Postepy Hig Med Dosw; 1981; 35(2):129-58. PubMed ID: 7038649
    [No Abstract]   [Full Text] [Related]  

  • 7. A cloned cell line, Mk1, possessing Ia antigens and accessory cell activity.
    Kyoizumi S; Noro N; Teshigawara K; Sakaguchi S; Masuda T
    J Immunol; 1982 Jun; 128(6):2586-94. PubMed ID: 6951877
    [No Abstract]   [Full Text] [Related]  

  • 8. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
    Jones B; Tite JP; Janeway CA
    J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface markers of a purified peritoneal eosinophil population from Mesocestoides corti-infected BALB/c male mice.
    Hogarth PM; Cruise KM; McKenzie IF; Mitchell GF
    J Immunol; 1980 Jan; 124(1):406-11. PubMed ID: 6153100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of monoclonal anti-thy-1.2: comparison of monoclonal IgM and IgG with xeno-antithymocyte preparations.
    Sherburne CG; Condie RM
    Transplant Proc; 1981 Mar; 13(1 Pt 1):504-8. PubMed ID: 6973851
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of new murine lymphocyte alloantigens: antisera prepared between C57L, 129 and related strains define new loci.
    Potter TA; McKenzie IF
    Immunogenetics; 1981; 12(3-4):351-69. PubMed ID: 6162796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theta antigen and immunogolbulin on a tissue-cultured mouse lymphoma.
    Boylston AW
    Immunology; 1973 May; 24(5):851-7. PubMed ID: 4541405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ
    Curr Top Hematol; 1980; 3():175-240. PubMed ID: 6276102
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression, distribution and specificity of Fc receptors for IgM on murine B cells.
    Mathur A; Lynch RG; Köhler G
    J Immunol; 1988 Sep; 141(6):1855-62. PubMed ID: 2971716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.
    Martin WJ; Esber E; Cotton WG; Rice JM
    Br J Cancer Suppl; 1973 Aug; 1():48-61. PubMed ID: 4804290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VIII. Expression and shedding of Fc gamma receptors on metastatic tumor cell variants.
    Schirrmacher V; Jacobs W
    J Supramol Struct; 1979; 11(1):105-11. PubMed ID: 522481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human lymphocyte receptors for the Fc ends of IgG].
    Revillard JP; Samarut C; Cordier G; Lethibichthuy ; Cohen J; Brochier J
    C R Seances Soc Biol Fil; 1980; 174(4):686-701. PubMed ID: 6449247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cytotoxic cells against solid tumors in mice. III. A comparison of effector cell antigenic phenotype and target cell recognition structures with those of NK cells.
    Lattime EC; Pecoraro GA; Stutman O
    J Immunol; 1981 May; 126(5):2011-4. PubMed ID: 7217680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of FcR alpha on murine lymphocytes by IgA in vitro.
    Yodoi J; Adachi M; Masuda T
    J Immunol; 1982 Feb; 128(2):888-94. PubMed ID: 6976386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.